Edition:
United Kingdom

Verastem Inc (VSTM.OQ)

VSTM.OQ on NASDAQ Stock Exchange Global Market

5.85USD
18 Oct 2018
Change (% chg)

$-0.18 (-2.99%)
Prev Close
$6.03
Open
$5.98
Day's High
$6.08
Day's Low
$5.79
Volume
459,407
Avg. Vol
674,052
52-wk High
$10.34
52-wk Low
$2.78

Latest Key Developments (Source: Significant Developments)

Verastem Oncology Announces Pricing Of Registered Direct Offering Of $150 Mln Of Convertible Notes
Friday, 12 Oct 2018 

Oct 11 (Reuters) - Verastem Inc ::VERASTEM ONCOLOGY ANNOUNCES PRICING OF REGISTERED DIRECT OFFERING OF $150 MILLION OF CONVERTIBLE NOTES.VERASTEM INC-PRICING OF AN OFFERING OF 5.00% CONVERTIBLE SENIOR NOTES DUE 2048 THROUGH A REGISTERED DIRECT OFFERING.  Full Article

Verastem Receives FDA Approval For Copiktratm - FDA Website
Monday, 24 Sep 2018 

Sept 24 (Reuters) - FDA Website::VERASTEM INC RECEIVES FDA APPROVAL FOR COPIKTRATM - FDA WEBSITE.  Full Article

Verastem Oncology Appoints Robert Gagnon As CFO
Wednesday, 29 Aug 2018 

Aug 29 (Reuters) - Verastem Inc ::VERASTEM ONCOLOGY APPOINTS ROBERT E. GAGNON AS CHIEF FINANCIAL OFFICER.SAYS ROBERT E. GAGNON APPOINTED CFO.APPOINTMENT OF ROBERT E. GAGNON AS CHIEF FINANCIAL OFFICER, EFFECTIVE AUGUST 28, 2018.  Full Article

Verastem Q2 Loss Per Share $0.30
Wednesday, 8 Aug 2018 

Verastem Inc ::VERASTEM ONCOLOGY REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS.Q2 LOSS PER SHARE $0.30.Q2 EARNINGS PER SHARE VIEW $-0.34 -- THOMSON REUTERS I/B/E/S.EXPECTS TO HAVE SUFFICIENT CASH AND CASH EQUIVALENTS TO FUND OPERATIONS INTO 2020.AS OF JUNE 30, 2018, VERASTEM ONCOLOGY HAD CASH AND CASH EQUIVALENTS OF $168.7 MILLION.  Full Article

Verastem Files For Mixed Shelf Of Upto $200 Mln
Tuesday, 24 Jul 2018 

July 24 (Reuters) - Verastem Inc ::VERASTEM INC FILES FOR MIXED SHELF OF UPTO $200 MILLION - SEC FILING.  Full Article

Verastem Oncology Announces $43.0 Million Offering Of Common Stock
Thursday, 14 Jun 2018 

June 14 (Reuters) - Verastem Inc ::VERASTEM ONCOLOGY ANNOUNCES $43.0 MILLION OFFERING OF COMMON STOCK.VERASTEM INC - OFFERING OF COMMON STOCK STOCK AT A PRICE OF $6.00 PER SHARE.  Full Article

Verastem's Julie Feder Resigned As Chief Financial Officer
Friday, 1 Jun 2018 

June 1 (Reuters) - Verastem Inc ::VERASTEM SAYS ON MAY 30, 2018, JULIE FEDER RESIGNED AS CHIEF FINANCIAL OFFICER OF VERASTEM - SEC FILING.VERASTEM INC - EFFECTIVE MAY 31, DANIEL PATERSON CO'S COO WILL SERVE AS PRINCIPAL FINANCIAL OFFICER ON AN INTERIM BASIS.  Full Article

Verastem Oncology Announces Public Offering Of Common Stock
Tuesday, 15 May 2018 

May 15 (Reuters) - Verastem Inc ::VERASTEM ONCOLOGY ANNOUNCES PUBLIC OFFERING OF COMMON STOCK.VERASTEM INC - COMMENCED A REGISTERED UNDERWRITTEN PUBLIC OFFERING OF $35 MILLION OF ITS SHARES OF COMMON STOCK.VERASTEM INC - HAS COMMENCED A REGISTERED UNDERWRITTEN PUBLIC OFFERING OF $35 MILLION OF ITS SHARES OF COMMON STOCK.  Full Article

Verastem Announces Increased Hercules Debt Facility
Thursday, 4 Jan 2018 

Jan 4 (Reuters) - Verastem Inc ::VERASTEM ANNOUNCES INCREASED HERCULES DEBT FACILITY.VERASTEM INC - ANNOUNCED ENTRY INTO AN AMENDMENT TO ITS LOAN AND SECURITY AGREEMENT WITH HERCULES CAPITAL INC.VERASTEM INC - ‍INCREASING ITS EXISTING BORROWING LIMIT UNDER LOAN FACILITY FROM $25 MILLION TO UP TO $50 MILLION IN FINANCING​.VERASTEM INC - ‍VERASTEM HAS RECEIVED FIRST $15 MILLION OF FINANCING UNDER ORIGINAL LOAN AND SECURITY AGREEMENT​.VERASTEM - ‍INCREASED LOAN FACILITY PROCEEDS TO BE USED FOR DEVELOPMENT PROGRAMS, INCLUDING REGULATORY & COMMERCIALIZATION ACTIVITIES FOR DUVELISIB​.  Full Article

Verastem Announces Pricing Of Public Offering Of Common Stock
Friday, 15 Dec 2017 

Verastem Inc ::VERASTEM ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK.VERASTEM INC - ANNOUNCED PRICING OF ITS PREVIOUSLY ANNOUNCED UNDERWRITTEN PUBLIC OFFERING OF APPROXIMATELY $25 MILLION OF SHARES OF ITS COMMON STOCK.  Full Article